{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-167905","form_type":"8-K","ticker":"GRTX","cik":"0001563577","company_name":"Galera Therapeutics, Inc.","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.406194+00:00","generated_at":"2026-06-14T00:10:16.462699+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Galera Therapeutics shareholders elect two Class I directors, ratify KPMG","bullets":["Michael Powell, Ph.D. elected with 15,141,283 votes for (76.2% of votes cast).","Linda West elected with 15,219,991 votes for (76.6% of votes cast); broker non-votes were 8,447,493.","KPMG LLP ratified as independent auditor for 2023 with 28,291,469 votes for, 9,547 against.","Turnout was 28,312,177 shares, representing 65.98% of outstanding common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-167905","json":"https://secwatch.observer/filing/0001193125-23-167905.json","markdown":"https://secwatch.observer/filing/0001193125-23-167905.md","text":"https://secwatch.observer/filing/0001193125-23-167905.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/0001193125-23-167905-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/d503234d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T00:10:16.462699+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8ec44c754e2ac8610c89b920bd860dc170ed44aa","claim":"Galera Therapeutics, Inc. shareholders approved Election of two Class I Directors to serve until the 2026 Annual Meeting of Stockholders at the 2023-06-14 meeting.","evidence_excerpt":"Item 1 — Election of two Class I Directors to serve until the 2026 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. NOMINEE Votes FOR Votes WITHHELD Broker Non-Votes Michael Powell, Ph.D. 15,141,283 4,723,401 8,447,493 Linda West 15,219,991 4,644,693 8,447,493","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/0001193125-23-167905-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"ab0ed6632986e97fef3236119c179e0c79ca58c4","claim":"Galera Therapeutics, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-14 meeting.","evidence_excerpt":"Item 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 28,291,469 9,547 11,161 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/0001193125-23-167905-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}